A highly sensitive HPLC method with automated on-line sample pre-treatment and fluorescence detection for determination of reboxetine in human plasma

Talanta

Volumn 80, Issue 3, 2010, Pages 1251-1256

  Khalil, Nasr Y ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Co sense; Fluorescence detection; HPLC; NBD F; Plasma; Reboxetine

Indexed keywords

ACETONITRILE; AUTOMATION; FILTRATION; FLUORESCENCE; PLASMA (HUMAN); PLASMAS; SODIUM COMPOUNDS;

CHROMATOGRAPHIC CONDITIONS; FLUORESCENCE DETECTION; HPLC; PRECOLUMN DERIVATIZATIONS; QUANTITATIVE DETERMINATIONS; REBOXETINE; RELATIVE STANDARD DEVIATIONS; SAMPLE PREPARATION PROCEDURE;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 71649087744     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2009.09.010     Document Type: Article

References (33)

1. Brenner E., Baldwin R.M., and Tamagnan G. Org. Lett. 7 (2005) 937
2. Kent J.M. Lancet 355 (2000) 911
3. Sacchetti G., Bernini M., Bianchetti A., Parini S., Invernizzi R.W., and Samanin R. Br. J. Pharmacol. 128 (1999) 1332
4. Montgomery S.A. J. Clin. Psychiatry 59 Suppl. 14 (1998) 26
5. Wong E.H.F., Sonders M.S., Amara S.G., Tinholt P.M., Piercey M.F.P., Hoffmann W.P., Hyslop D.K., Franklin S., Porsolt R.D., and Bonsignori A. Biol. Psychiatry 47 (2000) 818
6. Berzewski H., Van Moffaert M., and Gagiano C.A. Eur. Neuro-psychopharmacol. 7 (1997) S37
7. Tanum L. Acta Psychiatry Scand. 402 (2000) 37
8. Larrosa O., de la Llave Y., Bario S., Granizo J.J., and Garcia-Borreguero D. Sleep 24 (2001) 282
9. Dannon P.N., Iancu I., and Grunhaus L. Hum. Psychopharmacol. 17 (2002) 329
10. Lemke M.R. J. Clin. Psychiatry 63 (2002) 300
11. Holm J.K., and Spencer C.M. CNS Drugs 12 (1999) 65
12. Dostert P., Benedetti M.S., and Poggesi Eur I. Neuropsychopharmacology 7 (1997) S23
13. Wille S.M.R., Maudens K.E., Van Peteghem C.H., and Lambert W.E.E. J. Chromatogr. A 1098 (2005) 19
14. Wille S.M.R., Van Hee P., Neels H.M., Van Peteghem C.H., and Lambert W.E. J. Chromatogr. A 1176 (2007) 236
15. Ohman D., Norlander B., Peterson C., and Bengtsson F. Ther. Drug Monit. 23 (2001) 27
16. Frahnert C., Rao M.L., and Grasmader K. J. Chromatogr. B 794 (2003) 35
17. Hartter S., Weigmann H., and Hiemke C. J. Chromatogr. B 740 (2000) 135
18. Raggi M.A., Mandrioli R., Casamenti G., Volterra V., and Pinzauti S. J. Chromatogr. A 949 (2002) 23
19. Onal A., Sagirli A.O., Cetin S.M., and Toker S. Chromatographia 66 (2007) S103
20. Ohman D., Norlander B., Peterson C., and Bengtsson F. J. Chromatogr. A 947 (2002) 247
21. Cannazza G., Braghiroli D., Carrozzo M.M., Parenti C., Sabbioni C., Mandrioli R., Fanali S., and Raggi M.A. J. Pharm. Biomed. Anal. 48 (2008) 991
22. Oehman D., Cherma M.D., Norlander B., and Bengtsson F. Ther. Drug Monit. 25 (2003) 174
23. Turnpenny P., and Fraier D. J. Pharm. Biomed. Anal. 49 (2009) 133
24. Kirchherr H., and Kühn-Velten W.N. J. Chromatogr. B 843 (2006) 100
25. Darwish I.A., Mahmoud A.M., and Khalil N.Y. J. AOAC Int. 91 (2008) 1037
26. I.A. Darwish, A.A. Al-Majed, A.M. Mahmoud, N.Y. Khalil. J. AOAC. Int. (2009). In press.
27. Zhao X., Zang W., Zhao X., Wang S., Zheng X., and Zheng J. Chromatographia 65 (2007) 149
28. Saori N., Riho S., Reiko Y., Yoko K., Shoko M., Hikaru K., Sadahiko S., Shin O., and Susumu Y. Chem. Pharm. Bull. 56 (2008) 328
29. Sundd S., Manish J., Hiten S., Sapna G., Purav T., Ruchy S., and Bhushan L. J. Chromatogr. B 81 (2004) 247
30. Hattori H., Ito K., Iwai M., Arinobu T., Mizutani Y., Kumazawa T., Ishii A., Suzuki O., and Seno H. Forensic Toxicol. 25 (2007) 100
31. Imai K., Toyo Oka T., and Miyano H. Analyst 109 (1984) 1365
32. ICH Guideline. Q2 (R1): Validation of Analytical Procedure: Text and Methodology, London (2005)
33. HPLC Application Report No. 23: Direct Analysis of Drugs in Blood Plasma Using "Co-sense for BA" Bio-samples Pretreatment System, Shimadzu Corporation, Kyoto, Japan.